About this trial
The goal of this study is to evaluate an educational intervention that aims to reduce the number of unnecessary antibiotics prescribed by family physicians and nurse practitioners in British Columbia, Canada.
The intervention materials include a confidential personalized prescribing "portrait" and an evidence-based educational summary (therapeutics letter), accompanied by an introduction letter.
The main research questions are:
1. Will the intervention lead to a reduction in the overall number of antibiotics prescriptions started? 2. Will the intervention lead to a reduction in the proportion of antibiotics prescribed that are likely unnecessary, especially prescriptions for upper respiratory tract infections, acute bronchitis, acute sinusitis?
Researchers will conduct an intervention study with family physicians and nurse practitioners in British Columbia, Canada. Participant clinicians will be randomly assigned to one of two groups. The Early Group will consist of 80% of the participants and will receive the intervention (prescribing portrait, evidence summary, and introduction letter) at the start of the study. The Delayed Group will consist of 20% of participants and will receive the intervention about nine months later. This study design allows most practitioners to receive the intervention early while still allowing time to compare the two groups to assess the impact. To estimate the impact of the intervention, researchers will use administrative health data to compare the prescribing of the Early Group with prescribing of the Delayed Group.
Eligibility criteria
Qualifiers
A valid MSP billing number;
Status of Salaried, Private Practice, Temporary Licence, or Post Graduate;
Prescribed >100 dispensed medications in 2024.
Disqualifiers
Previously opted out of the Therapeutics Initiative Portrait program
Age <18 years at time of oral antibiotic dispensation;
Received PharmaCare benefits through the Palliative Care program at any time during the baseline or study period;
Hospitalized within 1 week prior to an antibiotic prescription at any time during the baseline or study period;
Trial design
Treatments tested in this trial
- Prescribing portrait audit and feedback
Treatment groups
Sponsors and collaborators
University of British Columbia
Lead sponsor
Ministry of Health, British Columbia
Collaborator
British Columbia Centre for Disease Control
Collaborator